市場調査レポート
商品コード
1387432
血友病治療市場レポート:2030年までの動向、予測、競合分析Hemophilia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
血友病治療市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
血友病治療の動向と予測
世界の血友病治療市場は、2024年から2030年までのCAGRが5.2%で、2030年までに推定184億米ドルに達すると予測されます。この市場の主な促進要因は、多数の血友病患者、血友病の予防的治療の利用、政府の有利な取り組みです。世界の血友病治療市場の将来は、血友病Aおよび血友病B市場における機会により有望視されています。
血友病治療市場の洞察
Lucintel社の予測によると、遺伝子組換え凝固因子濃縮製剤は、多くの遺伝子組換え技術を用いた製品があることから、予測期間中も最大セグメントであり続けると予想されます。
欧州は、血友病患者数の増加と技術的に先進的な製品に対する認知度の高まりから、予測期間中も最大地域であり続けると思われます。
Hemophilia Treatment Trends and Forecast
The future of the global hemophilia treatment market looks promising with opportunities in the hemophilia A and hemophilia B markets. The global hemophilia treatment market is expected to reach an estimated $18.4 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are large numbers of hemophilia patients, usage of prophylactic treatment for hemophilia, and favorable government initiatives.
A more than 150-page report is developed to help in your business decisions.
Hemophilia Treatment by Segment
The study includes a forecast for the global hemophilia treatment by type, drug therapy, end use, and region.
Hemophilia Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Hemophilia Treatment Market by Drug Therapy [Shipment Analysis by Value from 2018 to 2030]:
Hemophilia Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Hemophilia Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Hemophilia Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hemophilia treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hemophilia treatment companies profiled in this report include-
Hemophilia Treatment Market Insights
Lucintel forecasts that recombinant coagulation factor concentrates therapy will remain the largest segment over the forecast period because of the large number of recombinant technology products available for the treatment.
Europe will remain the largest region over the forecast period due to increasing number of hemophilic patients and rising awareness about technologically advanced products in the region.
Features of the Global Hemophilia Treatment Market
Market Size Estimates: Hemophilia treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hemophilia treatment market size by type, drug therapy, end use, and region in terms of value ($B).
Regional Analysis: Hemophilia treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different type, drug therapy, end use, and regions for the hemophilia treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hemophilia treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the hemophilia treatment market size?
Answer: The global hemophilia treatment market is expected to reach an estimated $18.4 billion by 2030.
Q2. What is the growth forecast for hemophilia treatment market?
Answer: The global hemophilia treatment market is expected to grow with a CAGR of 5.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the hemophilia treatment market?
Answer: The major drivers for this market are large numbers of hemophilia patients, usage of prophylactic treatment for hemophilia, and favorable government initiatives.
Q4. What are the major segments for hemophilia treatment market?
Answer: The future of the global hemophilia treatment market looks promising with opportunities in the hemophilia A and hemophilia B markets.
Q5. Who are the key hemophilia treatment market companies?
Answer: Some of the key hemophilia treatment companies are as follows:
Q6. Which hemophilia treatment market segment will be the largest in future?
Answer: Lucintel forecasts that recombinant coagulation factor concentrates therapy will remain the largest segment over the forecast period because of the large number of recombinant technology products available for the treatment.
Q7. In hemophilia treatment market, which region is expected to be the largest in next 5 years?
Answer: Europe will remain the largest region over the forecast period due to increasing number of hemophilic patients and rising awareness about technologically advanced products in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.